Filing Details
- Accession Number:
- 0001138723-19-000046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-04 16:25:59
- Reporting Period:
- 2019-10-31
- Accepted Time:
- 2019-11-04 16:25:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138723 | Accuray Inc | ARAY | Surgical & Medical Instruments & Apparatus (3841) | 770268932 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1159917 | Joshua Levine | 1310 Chesapeake Terrace Sunnyvale CA 94089 | President & Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-10-31 | 28,081 | $2.61 | 931,063 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-10-31 | 418,490 | $0.00 | 1,349,553 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2019-10-31 | 923,020 | $0.00 | 923,020 | $2.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 923,020 | 2029-10-31 | No | 4 | A | Direct |
Footnotes
- Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
- Fiscal year 2020 Performance award with Performance Measurement Period from 7/1/2019 to 6/30/2020. If the performance metrics are met the vesting will occur on the last day of the quarter for two years beginning 9/30/2020 contingent on continued employment.
- The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.
Billionaire Hedge Funds
